Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -13.72% is 81% below its 5-year average of -7.60%, around the middle of its 5-year range (-61.20%–34.04%).
38.93% above its 12-month average of -22.47%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2025 (2025-12-31): -24.26%.
NET PROFIT MARGIN
-13.72%
NET PROFIT MARGIN AVG TTM
-22.47%
NET PROFIT MARGIN AVG 3Y
-19.19%
NET PROFIT MARGIN AVG 5Y
-7.60%
NET PROFIT MARGIN AVG 10Y
-4.59%
NET PROFIT MARGIN AVG 15Y
-24.79%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+38.93%
CURRENT VS 3Y AVG
+28.50%
CURRENT VS 5Y AVG
-80.55%
CURRENT VS 10Y AVG
-198.98%
CURRENT VS 15Y AVG
+44.65%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-5176.92%
vs the sector median at left
InterCure Ltd.
Market Cap
$63.02M
Net Profit Margin
-13.72%
TTM Avg
-22.47%
3Y Avg
-19.19%
5Y Avg
-7.60%
Market Cap
$63.16M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2871.11%
5Y Avg
-2144.71%
Market Cap
$63.56M
Net Profit Margin
-41.36%
TTM Avg
-52.43%
3Y Avg
-63.29%
5Y Avg
-45.57%
Market Cap
$62.17M
Net Profit Margin
-621.71%
TTM Avg
-10746.07%
3Y Avg
-5373.04%
5Y Avg
-3582.02%
Market Cap
$61.72M
Net Profit Margin
-22.52%
TTM Avg
-11.22%
3Y Avg
-69.63%
5Y Avg
-131.75%
Market Cap
$61.12M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$65.22M
Net Profit Margin
-235.00%
TTM Avg
-200.38%
3Y Avg
-100.19%
5Y Avg
-66.80%
Market Cap
$60.22M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$66.01M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-205.11%
5Y Avg
-156.77%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InterCure Ltd. (INCR) | $63.02M | -13.72% | -22.47% | -19.19% | -7.60% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.16M | 0.00% | 0.00% | -2871.11% | -2144.71% |
| Alps Group Inc (ALPS)vs › | $63.56M | -41.36% | -52.43% | -63.29% | -45.57% |
| RenovoRx, Inc. (RNXT)vs › | $62.17M | -621.71% | -10746.07% | -5373.04% | -3582.02% |
| Heron Therapeutics, Inc. (HRTX)vs › | $61.72M | -22.52% | -11.22% | -69.63% | -131.75% |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.22M | -235.00% | -200.38% | -100.19% | -66.80% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.22M | 0.00% | 0.00% | 0.00% | 0.00% |
| XBiotech Inc. (XBIT)vs › | $66.01M | 0.00% | 0.00% | -205.11% | -156.77% |
| iBio, Inc. (IBIO)vs › | $66.24M | -33044.00% | -18819.13% | -12177.01% | -8726.92% |
Operating Margin
2.5%
Net Profit Margin
-13.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-31 | -24.26% |
| 2025-09-30 | -24.26% |
| 2025-06-30 | -1.31% |
| 2025-03-31 | -1.31% |
| 2024-12-31 | -61.20% |
| 2024-09-30 | -61.20% |
| 2024-06-30 | 1.14% |
| 2024-03-31 | 1.14% |
| 2023-12-31 | -45.63% |
| 2023-09-30 | -45.63% |
| 2023-06-30 | 4.77% |
| 2023-03-31 | 0.20% |
| 2022-12-31 | 8.10% |
| 2022-09-30 | 7.21% |
| 2022-06-30 | 16.41% |
| 2022-03-31 | 15.33% |
| 2021-12-31 | -3.85% |
| 2021-09-30 | -2.66% |
| 2021-06-30 | 13.69% |
| 2021-03-31 | 9.72% |
| 2020-12-31 | 34.04% |
| 2020-09-30 | 7.71% |
| 2020-06-30 | -8.74% |
| 2020-03-31 | -1108.45% |
| 2019-12-31 | -751.91% |
| 2019-09-30 | -596.92% |
| 2019-06-30 | -415.56% |
| 2019-03-31 | 2193.67% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | -1797.33% |
| 2015-09-30 | -270.68% |
| 2015-06-30 | 37.19% |
| 2015-03-31 | -47.07% |
| 2014-12-31 | -60.60% |
| 2014-09-30 | -135.82% |
| 2014-06-30 | -83.44% |
| 2014-03-31 | -26.07% |
| 2013-12-31 | -66.28% |
| 2013-09-30 | -134.83% |
| 2013-06-30 | -82.01% |
| 2013-03-31 | -53.48% |
| 2012-12-31 | -202.60% |
| 2012-09-30 | 2775.47% |
| 2012-06-30 | -17.01% |
| 2012-03-31 | -138.61% |
| 2011-12-31 | -56.35% |
| 2011-09-30 | -56.35% |
| 2011-06-30 | -56.35% |
| 2011-03-31 | -56.35% |
| 2010-12-31 | -94.98% |
| 2010-09-30 | -94.98% |
| 2010-06-30 | -94.98% |
| 2010-03-31 | -94.98% |
